drugset / Trial / NCT01116778
the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis
Phase 3
Completed
236 enrolled
GenMont Biotech Incorporation
Biomedical Development Corporation · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of probiotics eN-Lac® capsules (Lactobacillus paracasei GMNL-32) for the treatment of children with perennial allergic rhinitis(PAR).
Timeline
- Start
- 2010-05
- Primary completion
- 2012-01
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | eN-Lac® | Other / unclassified | 2e+09 unknown | Oral |